Updating results

47 results for Cognitive Behaviour Therapy

Sort: Relevance | Date

Cognitive behavioural therapy for people with atrial fibrillation:- What is the clinical and cost effectiveness of cognitive behavioural therapy (CBT) compared with usual care for people with newly diagnosed atrial fibrillation?

Cognitive behavioural therapy for people with atrial fibrillation:- What is the clinical and cost effectiveness of...

Research recommendation Published June 2015

What is the relative effectiveness of sertraline compared with cognitive behavioural therapy (CBT) in people with generalised anxiety disorder (GAD) that has not responded to guided self-help and psychoeducation in a stepped-care model?

is the relative effectiveness of sertraline compared with cognitive behavioural therapy (CBT) in people with generalised...

Research recommendation Published June 2015

Psychological interventions to manage chronic headache disorders:- Does a psychological intervention such as cognitive behavioural therapy (CBT) improve headache outcomes and quality of life for people with chronic headache disorders?

headache disorders:- Does a psychological intervention such as cognitive behavioural therapy (CBT) improve headache...

Research recommendation Published June 2015

In well-defined panic disorder, what is the clinical and cost effectiveness of two cognitive behavioural therapy (CBT) based low-intensity interventions (CCBT and guided bibliotherapy) compared with a waiting-list control?

disorder, what is the clinical and cost effectiveness of two cognitive behavioural therapy (CBT) based low-intensity...

Research recommendation Published June 2015

Health app: Sleepio for adults with poor sleep (MIB129)

Advice on the use of the Sleepio health app to help adults with poor sleep improve sleep through cognitive behavioural therapy, to aid local decision-making

Medtech innovation briefing Published November 2017

Alpha-Stim AID for anxiety (MIB193)

Advice on the use of Alpha-Stim AID for anxiety to aid local decision making

Medtech innovation briefing Published September 2019

First-choice antidepressant use in adults with depression or generalised anxiety disorder (KTT8)

depression in children and young people (recommendations on psychological therapies and antidepressants were updated in March 2015) and...

Key therapeutic topic Published January 2015 Last updated February 2016

Acoustic CR Neuromodulation for adults with chronic subjective tonal tinnitus (MIB5)

Advice on the use of the Acoustic CR Neuromodulation system for adults with chronic subjective tonal tinnitus to aid local decision-making

Medtech innovation briefing Published June 2014

Irritable bowel syndrome with constipation in adults: linaclotide (ESNM16)

Summary of the evidence on linaclotide for irritable bowel syndrome (IBS) with constipation in adults to inform local NHS planning and decision-making

Evidence summary Published April 2013

Antipsychotics in people living with dementia (KTT7)

carers to support people living with dementia. This includes managing non-cognitive symptoms of dementia such as agitation, aggression,...

Key therapeutic topic Published January 2015 Last updated September 2019

Management of aggression, agitation and behavioural disturbances in dementia: carbamazepine (ESUOM40)

Summary of the evidence on carbamazepine for managing aggression, agitation and behavioural disturbances in people with dementia..

Evidence summary Published March 2015

Attention deficit hyperactivity disorder in children and young people: guanfacine prolonged-release (ESNM70)

Summary of the evidence on guanfacine prolonged-release for attention deficit hyperactivity disorder (ADHD) to inform local NHS planning and decision-making

Evidence summary Published March 2016

Schizophrenia: omega-3 fatty acid medicines (ESUOM19)

Summary of the evidence on omega-3 fatty acid medicines for treating schizophrenia to inform local NHS planning and decision-making

Evidence summary Published September 2013

Attention deficit hyperactivity disorder in children and young people: clonidine (ESUOM8)

Summary of the evidences on clonidine for attention deficit hyperactivity disorder (ADHD) in children and young people..

Evidence summary Published April 2013

Is contingency management effective in reducing alcohol consumption in people who misuse alcohol compared with standard care?

effective current treatment (for example, cognitive behavioural therapies and social network and environment-based...

Research recommendation Published June 2015

Is acupuncture effective in reducing alcohol consumption compared with standard care?

psychological treatments (for example, cognitive behavioural therapies and social network and environment-based therapies)...

Research recommendation Published June 2015

Oestrogen deficiency symptoms in postmenopausal women: conjugated oestrogens and bazedoxifene acetate (ES3)

Summary of the evidence on conjugated oestrogens and bazedoxifene acetate for oestrogen deficiency symptoms to inform local NHS planning and decision-making

Evidence summary Published December 2016

Hypersalivation: oral glycopyrronium bromide (ESUOM15)

Summary of the evidence on oral glycopyrronium bromide for treating hypersalivation (sialorrhoea) to inform local NHS planning and decision-making

Evidence summary Published July 2013

Sleep disorders in children and young people with attention deficit hyperactivity disorder: melatonin (ESUOM2)

Summary of the evidence on melatonin for sleep disorders in children and young people with attention deficit hyperactivity disorder (ADHD)..

Evidence summary Published January 2013

Parkinson's disease with motor fluctuations: safinamide (ES6)

Summary of the evidence on safinamide for treating Parkinson’s disease with motor fluctuations to inform local NHS planning and decision-making

Evidence summary Published February 2017

Restless legs syndrome: Oxycodone/naloxone prolonged release (ESNM67)

Summary of the evidence on oxycodone/naloxone prolonged release for treating restless leg syndrome (RLS) to inform local NHS planning and decision-making

Evidence summary Published December 2015

Specific versus generic CBT for children and young people with social anxiety disorder:- What is the clinical and cost effectiveness of specific CBT for children and young people with social anxiety disorder compared with generic anxiety-focused CBT?

versus generic CBT for children and young people with social anxiety disorder:- What is the clinical and cost effectiveness of specific...

Research recommendation Published June 2015

Narcolepsy with or without cataplexy in adults: pitolisant (ES8)

Summary on the evidence on pitolisant for treating narcolepsy with or without cataplexy to inform local NHS planning and decision-making

Evidence summary Published March 2017

Smartinhaler for asthma (MIB90)

Advice on the use of Smartinhaler for monitoring the activation of asthma inhalers to aid local decision-making

Medtech innovation briefing Published January 2017

Individual versus group CBT for children and young people with social anxiety disorder:- What is the clinical and cost effectiveness of individual and group CBT for children and young people with social anxiety disorder?

versus group CBT for children and young people with social anxiety disorder:- What is the clinical and cost effectiveness of individual...

Research recommendation Published June 2015

Interventions for PTSD symptoms in people with psychosis and schizophrenia:- What is the benefit of a CBT-based trauma reprocessing intervention on PTSD symptoms in people with psychosis and schizophrenia?

symptoms in people with psychosis and schizophrenia:- What is the benefit of a CBT-based trauma reprocessing intervention on PTSD...

Research recommendation Published June 2015

What is the clinical and cost effectiveness for family intervention combined with individual CBT in the treatment of children and young people considered to be at high risk of developing psychosis and their parents or carers?

clinical and cost effectiveness for family intervention combined with individual CBT in the treatment of children and young people...

Research recommendation Published June 2015

What is the clinical and cost effectiveness, post-treatment and at longer-term follow‑up, of psychological therapies in children aged 5 to 11 years with mild or moderate to severe depression?

effectiveness, post-treatment and at longer-term follow‑up, of psychological therapies in children aged 5 to 11 years with mild or...

Research recommendation Published October 2019

What is the clinical and cost effectiveness of psychological intervention alone, compared with antipsychotic medication and compared with psychological intervention and antipsychotic medication combined, in young people with first episode psychosis?

interventions most likely to have an impact is family intervention and individual CBT. The key outcomes should include symptoms, relapse...

Research recommendation Published June 2015

People who choose not to take antipsychotic medication:- What is the clinical and cost effectiveness of psychological intervention alone, compared with treatment as usual, in people with psychosis or schizophrenia who choose not to take antipsychotic medication?

or lack of efficacy. There is evidence that psychological interventions (CBT and family intervention) as an adjunct to antipsychotic...

Research recommendation Published June 2015

Combined interventions for adults with social anxiety disorder:- What is the clinical and cost effectiveness of combined psychological and pharmacological interventions compared with either intervention alone in the treatment of adults with social anxiety disorder?

Why this is important:- There is evidence for the effectiveness of both CBT and medication, in particular SSRIs, in the treatment of...

Research recommendation Published June 2015

Generalised anxiety disorder: quetiapine (ESUOM12)

Summary of the evidence on quetiapine monotherapy for treating generalised anxiety disorder (GAD) to inform local NHS planning and decision-making

Evidence summary Published May 2013

Treating comorbid anxiety in children and young people with autism:- What is the comparative clinical and cost effectiveness of pharmacological and psychosocial interventions for anxiety disorders in children and young people with autism?

explanatory notes(if applicable) Why this is important:- Early trials of CBT for anxiety in children and young people with autism have...

Research recommendation Published June 2015

The role of parents in the treatment of children and young people with social anxiety disorder:- What is the best way of involving parents in the treatment of children and young people (at different stages of development) with social anxiety disorder?

should be tested using an RCT design with standard care (for example, group CBT) as the comparison. It should report short- and...

Research recommendation Published June 2015